Literature DB >> 16483848

Role of peroxynitrite in the pathogenesis of cardiovascular complications of diabetes.

Pál Pacher1, Csaba Szabó.   

Abstract

Hyperglycemic episodes, which complicate even well-controlled cases of diabetes, lead to increased polyol pathway flux, activation of protein kinase C and accelerated non-enzymatic formation of advanced glycation end products. Many of these pathways become activated in response to the production of superoxide anion. Superoxide can interact with nitric oxide, forming the potent cytotoxin peroxynitrite. Peroxynitrite attacks various biomolecules in the vascular endothelium, vascular smooth muscle and myocardium, eventually leading to cardiovascular dysfunction via multiple mechanisms. This review focuses on emerging evidence suggesting that peroxynitrite plays a key role in the pathogenesis of the cardiovascular complications of diabetes, which underlie the development and progression of diabetic retinopathy, neuropathy and nephropathy.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16483848      PMCID: PMC2228269          DOI: 10.1016/j.coph.2006.01.001

Source DB:  PubMed          Journal:  Curr Opin Pharmacol        ISSN: 1471-4892            Impact factor:   5.547


  52 in total

1.  Part I: pathogenetic role of peroxynitrite in the development of diabetes and diabetic vascular complications: studies with FP15, a novel potent peroxynitrite decomposition catalyst.

Authors:  Csaba Szabó; Jon G Mabley; Suzanne M Moeller; Roman Shimanovich; Pál Pacher; László Virag; Francisco G Soriano; John H Van Duzer; William Williams; Andrew L Salzman; John T Groves
Journal:  Mol Med       Date:  2002-10       Impact factor: 6.354

2.  Acute hyperglycemia induces nitrotyrosine formation and apoptosis in perfused heart from rat.

Authors:  Antonio Ceriello; Lisa Quagliaro; Michele D'Amico; Clara Di Filippo; Raffaele Marfella; Francesco Nappo; Liberato Berrino; Francesco Rossi; Dario Giugliano
Journal:  Diabetes       Date:  2002-04       Impact factor: 9.461

Review 3.  Vascular targets of redox signalling in diabetes mellitus.

Authors:  M M Spitaler; W F Graier
Journal:  Diabetologia       Date:  2002-04       Impact factor: 10.122

4.  Poly(ADP-Ribose) polymerase is activated in subjects at risk of developing type 2 diabetes and is associated with impaired vascular reactivity.

Authors:  Csaba Szabó; Anne Zanchi; Katalin Komjáti; Pál Pacher; Andrzej S Krolewski; William C Quist; Frank W LoGerfo; Edward S Horton; Aristidis Veves
Journal:  Circulation       Date:  2002-11-19       Impact factor: 29.690

5.  Effects of angiotensin II on vascular endothelial cells: formation of receptor-mediated reactive nitrogen species.

Authors:  Michael J Mihm; Suvara K Wattanapitayakul; Sheng-Fu Piao; Dale G Hoyt; John Anthony Bauer
Journal:  Biochem Pharmacol       Date:  2003-04-01       Impact factor: 5.858

6.  Mechanisms of increased vascular superoxide production in human diabetes mellitus: role of NAD(P)H oxidase and endothelial nitric oxide synthase.

Authors:  Tomasz J Guzik; Shafi Mussa; Daniela Gastaldi; Jerzy Sadowski; Chandi Ratnatunga; Ravi Pillai; Keith M Channon
Journal:  Circulation       Date:  2002-04-09       Impact factor: 29.690

7.  Pharmacologic inhibition of poly(adenosine diphosphate-ribose) polymerase may represent a novel therapeutic approach in chronic heart failure.

Authors:  Pál Pacher; Lucas Liaudet; Jon g Mabley; Katalin Komjáti; Csaba Szabó
Journal:  J Am Coll Cardiol       Date:  2002-09-04       Impact factor: 24.094

Review 8.  The therapeutic potential of poly(ADP-ribose) polymerase inhibitors.

Authors:  László Virág; Csaba Szabó
Journal:  Pharmacol Rev       Date:  2002-09       Impact factor: 25.468

9.  Evidence for an independent and cumulative effect of postprandial hypertriglyceridemia and hyperglycemia on endothelial dysfunction and oxidative stress generation: effects of short- and long-term simvastatin treatment.

Authors:  Antonio Ceriello; Claudio Taboga; Laura Tonutti; Lisa Quagliaro; Ludovica Piconi; Bruno Bais; Roberto Da Ros; Enrico Motz
Journal:  Circulation       Date:  2002-09-03       Impact factor: 29.690

10.  Role of hyperglycemia in nitrotyrosine postprandial generation.

Authors:  Antonio Ceriello; Lisa Quagliaro; Barbara Catone; Roberta Pascon; Marta Piazzola; Bruno Bais; Giampiero Marra; Laura Tonutti; Claudio Taboga; Enrico Motz
Journal:  Diabetes Care       Date:  2002-08       Impact factor: 19.112

View more
  58 in total

Review 1.  Regulation of mitochondrial bioenergetic function by hydrogen sulfide. Part II. Pathophysiological and therapeutic aspects.

Authors:  Katalin Módis; Eelke M Bos; Enrico Calzia; Harry van Goor; Ciro Coletta; Andreas Papapetropoulos; Mark R Hellmich; Peter Radermacher; Frédéric Bouillaud; Csaba Szabo
Journal:  Br J Pharmacol       Date:  2014-04       Impact factor: 8.739

Review 2.  Role of nitrosative stress in the pathogenesis of diabetic vascular dysfunction.

Authors:  Csaba Szabo
Journal:  Br J Pharmacol       Date:  2009-02-06       Impact factor: 8.739

3.  SR-135, a peroxynitrite decomposing catalyst, enhances β-cell function and survival in B6D2F1 mice fed a high fat diet.

Authors:  Michael Johns; Robert Fyalka; Jennifer A Shea; William L Neumann; Smita Rausaria; Eliwaza Naomi Msengi; Maryam Imani-Nejad; Harry Zollars; Timothy McPherson; Joseph Schober; Joshua Wooten; Guim Kwon
Journal:  Arch Biochem Biophys       Date:  2015-04-29       Impact factor: 4.013

4.  New therapeutic and biomarker discovery for peripheral diabetic neuropathy: PARP inhibitor, nitrotyrosine, and tumor necrosis factor-{alpha}.

Authors:  Viktor R Drel; Sergey Lupachyk; Hanna Shevalye; Igor Vareniuk; Weizheng Xu; Jie Zhang; Nicholas A Delamere; Mohammad Shahidullah; Barbara Slusher; Irina G Obrosova
Journal:  Endocrinology       Date:  2010-03-31       Impact factor: 4.736

Review 5.  Molecular insights and therapeutic targets for diabetic endothelial dysfunction.

Authors:  Jian Xu; Ming-Hui Zou
Journal:  Circulation       Date:  2009-09-29       Impact factor: 29.690

6.  Resveratrol improves left ventricular diastolic relaxation in type 2 diabetes by inhibiting oxidative/nitrative stress: in vivo demonstration with magnetic resonance imaging.

Authors:  Hanrui Zhang; Brandon Morgan; Barry J Potter; Lixin Ma; Kevin C Dellsperger; Zoltan Ungvari; Cuihua Zhang
Journal:  Am J Physiol Heart Circ Physiol       Date:  2010-07-30       Impact factor: 4.733

7.  Nitrosative stress plays an important role in Wnt pathway activation in diabetic retinopathy.

Authors:  Qiuping Liu; Jingming Li; Rui Cheng; Ying Chen; Kyungwon Lee; Yang Hu; Jinglin Yi; Zuguo Liu; Jian-xing Ma
Journal:  Antioxid Redox Signal       Date:  2012-10-15       Impact factor: 8.401

8.  Angiotensin II inhibits insulin-stimulated GLUT4 translocation and Akt activation through tyrosine nitration-dependent mechanisms.

Authors:  Alfredo Csibi; David Communi; Nathalie Müller; Serge P Bottari
Journal:  PLoS One       Date:  2010-04-07       Impact factor: 3.240

Review 9.  Interplay of oxidative, nitrosative/nitrative stress, inflammation, cell death and autophagy in diabetic cardiomyopathy.

Authors:  Zoltán V Varga; Zoltán Giricz; Lucas Liaudet; György Haskó; Peter Ferdinandy; Pál Pacher
Journal:  Biochim Biophys Acta       Date:  2014-07-02

10.  Peroxynitrite-induced protein nitration is responsible for renal mitochondrial damage in diabetic rat.

Authors:  J H Liang; Y N Li; J S Qi; X X Jia
Journal:  J Endocrinol Invest       Date:  2009-09-11       Impact factor: 4.256

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.